[1]
“Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices”, Clinics, vol. 67, no. 11, pp. 1349–1349, Nov. 2012, doi: 10.6061/clinics/2012(11)22.